ARCHIVES

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves More Than $25 Million In Contract Recompetitions, Two New Contracts

February 23, 1990

Also in this 8-page issue: Use cancer mortality, not 5-year survival, to track progress against cancer, researchers say.

July 29, 2005

Jury Awards $14 Million To Medenica Patient

February 24, 1995

DCPC Concepts Approved

September 27, 1985

Virus Cancer Program Report On Scientific Activities

August 1, 1975

Decline In Breast Cancer May Be Related to Drop In HT

March 25, 2011